TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide

Current Biology

Volumn 8, Issue 1, 1998, Pages 1-10

  Braud, Veronique M ^a   Allan, David S J ^a   Wilson, Douglas ^b   McMichael, Andrew J ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; ANTHROPOIDEA;

EID: 0031963752     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(98)70014-4     Document Type: Article

References (54)

1. Cerundolo V, Braud V: Cell biology of MHC class I molecules. In HLA and MHC genes, Molecules and Function. Edited by Browning M, McMichael A. Oxford: Bios Scientific Publisher Ltd; 1996:193-223.
2. 2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 1994, 368:864-867.
3. 2-microglobulin: major histocompatibility complex class I heavy chain intermediate dissociates from calnexin and then is stabilized by binding peptide. J Exp Med 1994, 180:2163-2171.
4. Noßner E, Parham P: Species-specific differences in chaperone interaction of human and mouse major histocompatibility complex class I molecules. J Exp Med 1995, 181:327-337.
5. Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P: Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 1996, 5:103-114.
6. Suh W, Cohen-Doyle MF, Früh K, Wang K, Peterson PA, Williams DB: Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 1994, 264:1322-1326.
7. Lewis JW, Neisig A, Neefjes J, Elliott T: Point mutations in the alpha 2 domain of HLA-A2.1 define a functionally relevant interaction with TAP. Curr Biol 1996, 6:873-883.
8. Peace Brewer AL, Tussey LG, Matsui M, Li G, Quinn DG, Frelinger JA: A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL. Immunity 1996, 4:505-514.
9. Lee N, Malacko AR, Ishitani A, Chen M, Bajorath J, Marquardt H, Geraghty DE: The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 1995, 3:591-600.
10. Diehl M, Munz C, Keiholz W, Stevanovic S, Holmes N, Loke YW, Rammensee H: Nonclassical HLA-G molecules are classical peptide presenters. Curr Biol 1996, 6:305-314.
11. + T lymphocytes. Science 1995, 268:863-865.
12. Castano AR, Tangri S, Miller JEW, Holcombe HR, Jackson MR, Huse WD, et al.: Peptide binding and presentation by mouse CD1. Science 1995, 269:223-226.
13. + T cells. Nature 1994, 372:691-694.
14. Sieling PA, Chatterjee D, Porcelli SA, Prigozy TI, Mazzaccaro RJ, Soriano T, et al.: CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 1995, 269:227-230.
15. Joyce S, Tabaczewski P, Angeletti RH, Nathenson SG, Stroynowski I: A nonpolymorphic major histocompatibility complex class Ib molecule binds a large array of diverse self-peptides. J Exp Med 1994, 179:579-588.
16. Fisher Lindahl FK, Hermel E, Loveland BE, Wang CR: Maternally transmitted antigen of mice: a model transplantation antigen. Annu Rev Immunol 1991, 9:351-372.
17. Attaya M, Jameson S, Martinez CK, Hermel E, Aldrich C, Forman J, et al.: Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature 1992, 355:647-649.
18. Aldrich CJ, Decloux A, Woods AS, Cotter RJ, Soloski MJ, Forman J: Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell 1994, 79:649-658.
19. b. J Immunol 1997, 158:2183-2191.
20. Wei ML, Cresswell P: HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 1992, 356:443-446.
21. Henderson RA, Michel H, Sakaguchi K, Shabanowitz J, Appella E, Hunt DF, Engelhard VH: HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 1992, 255:1264-1266.
22. Hombach J, Pircher H, Tonegawa S, Zinkernagel RM: Strictly transporter of antigen presentation (TAP)-dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal sequence of a virus protein. J Exp Med 1995, 182:1615-1619.
23. b signal sequence requires the transporter-associated with antigen presentation. J Immunol 1997, 158:685-692.
24. Cotterill LA, Stauss HJ, Millrain MM, Pappin DJC, Rahman D, Canas B, et al:. Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide. Eur J Immunol 1997, 27:2123-2132.
25. Braud V, Jones EY, McMichael A: The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol 1997, 27:1164-1169.
26. Ulbrecht M, Honka T, Person S, Johnson JP, Weiss EH: The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein. J Immunol 1992, 149:2945-2953.
27. Ulbrecht M, Kellermann J, Johnson JP, Weiss EH: Impaired intracellular transport and cell surface expression of nonpolymorphic HLA-E: evidence for inefficient peptide binding. J Exp Med 1992, 176:1083-1090.
28. Geraghty DE, Stockschleader M, Ishitani A, Hansen JA: Polymorphism at the HLA-E locus predates most HLA-A and -B polymorphism. Hum Immunol 1992, 33:174-184.
29. 2-microglobulin: differential effects of inhibition of glycosylation on class I subunit association. Eur J Immunol 1988, 18:801-810.
30. Hill A, Takiguchi M, McMichael A: Different rates of HLA class I molecule assembly which are determined by amino acid sequence in the a2 domain, Immunogenetics 1993, 37:95-101.
31. Gobin SJP, Wilson L, Keijser SV, van den Elsen PJ: Antigen processing and presentation by human trophoblast-derived cell lines. J Immunol 1997, 158:3587-3592.
32. Greenwood R, Shimizu Y, Sekhon GS, DeMars R: Novel allelespecific, post-translational reduction in HLA class I surface expression in a mutant human B cell line. J Immunol 1994, 153:5525-5536.
33. Grandea AG, Androlewicz MJ, Athwal RS, Geraghty DE, Spies T: Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science 1995, 270:105-108.
34. Salter RD, Cresswell P: Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J 1986, 5:943-949.
35. DeMars R, Chang C, Shaw S, Reitnauer PJ, Sondel PM: Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. 1. Reduced proliferation responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens. Hum Immunol 1984, 11:77-97.
36. Kelly A, Powis SH, Kerr LA, Mockridge I, Elliott T, Bastin J, et al.: Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature 1992, 355:641-644.
37. Soloski MJ, Decloux A, Aldrich CJ, Forman J: Structural and functional characteristics of the class Ib molecule Qa-1. Immunol Rev 1995, 147:67-89.
38. Connolly DJ, Cotterill LA, Hederer RA, Thorpe CJ, Travers PJ, McVey JH, et al.: A cDNA clone encoding the mouse Qa-1a histocompatibility antigen and proposed structure of the putative peptide binding site. J Immunol 1993, 151:6089-6098.
39. Koller BH, Geraghty DE, Shimizu Y, Demars R, Orr HT: HLA-E. A novel HLA class I gene expressed in resting T lymphocytes. J Immunol 1988, 141:897-904.
40. Shimizu Y, Geraghty DE, Koller BH, Orr HT, Demars R: Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc Natl Acad Sci USA 1988, 85:227-231.
41. Wei XH, Orr HT: Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissue. Hum Immunol 1990, 29:131-142.
42. Lyko F, Martoglio B, Jungnickel B, Rapoport TA, Dobberstein B: Signal sequence processing in rough microsomes. J Biol Chem 1995, 270:19873-19878.
43. Rammensee HG, Friede T, Stevanoviic S: MHC ligands and peptide motifs: first listing. Immunogenetics 1995, 41:178-228.
44. Barber LD, Gillece Castro B, Percival L, Li X, Clayberger C, Parham P: Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes. Curr Biol 1995, 5:179-190.
45. Roelse J, Gromme M, Momburg F, Hammerling G, Neefjes J: Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J Exp Med 1994, 180:1591-1597.
46. Neisig A, Roelse J, Sijts AJ, Ossendorp F, Feltkamp MC, Kast WM, et al.: Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. J Immunol 1995, 154:1273-1279.
47. Wiertz EJHJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL: The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 1996, 84:769-779.
48. Hughes EA, Hammond C, Cresswell P: Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc Natl Acad Sci USA 1997, 94:1896-1901.
49. Houlihan JM, Biro PA, Harper HM, Jenkinson HJ, Holmes CH: The human amnion is a site of MHC class Ib expression: evidence for the expression of HLA-E and HLA-G. J Immunol 1995, 154:5665-5674.
50. + and HLA-A2. Nature 1997, 387:630-634.
51. + T cells. Immunity 1995, 2:177-184.
52. + T cells expressing Vβ 8 TCR: a role of the Qa-1 molecule. Immunity 1995, 2:185-194.
53. Bunce M, O'Neill CM, Barnardo MCNM, Krausa P, Browning MJ, Morris PJ, Welsh KI: Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995, 46:355-367.
54. Krausa P, Browning MJ: A comprehensive PCR-SSP typing system for identification of HLA-A locus alleles. Tissue Antigens 1996, 47:237-244.